APA (7th ed.) Citation

Waked, A., Crabbé, M., Neirinckx, V., Pérez, S. R., Wellens, J., Rogister, B., . . . Vermeulen, K. (2024). Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma. EJNMMI Radiopharmacy & Chemistry, 9(1), 1. https://doi.org/10.1186/s41181-024-00282-y

Chicago Style (17th ed.) Citation

Waked, Anthony, Melissa Crabbé, Virginie Neirinckx, Sunay Rodriguez Pérez, Jasmien Wellens, Bernard Rogister, M. Abderrafi Benotmane, and Koen Vermeulen. "Preclinical Evaluation of CXCR4 Peptides for Targeted Radionuclide Therapy in Glioblastoma." EJNMMI Radiopharmacy & Chemistry 9, no. 1 (2024): 1. https://doi.org/10.1186/s41181-024-00282-y.

MLA (9th ed.) Citation

Waked, Anthony, et al. "Preclinical Evaluation of CXCR4 Peptides for Targeted Radionuclide Therapy in Glioblastoma." EJNMMI Radiopharmacy & Chemistry, vol. 9, no. 1, 2024, p. 1, https://doi.org/10.1186/s41181-024-00282-y.